Immune Checkpoint Inhibitors in Cancer, 1st Edition
Authors :
Fumito Ito & Marc Ernstoff
Date of Publication: 08/2018
Get a quick, expert overview of the latest clinical information and guidelines for cancer checkpoint inhibitors and their implications for specific types of cancers. This practical title by Drs. Fumito Ito and Marc Ernstoff synthesizes the most up-to ...view more
Get a quick, expert overview of the latest clinical information and guidelines for cancer checkpoint inhibitors and their implications for specific types of cancers. This practical title by Drs. Fumito Ito and Marc Ernstoff synthesizes the most up-to-date research and clinical guidance available on immune checkpoint inhibitors and presents this information in a compact, easy-to-digest resource. It’s an ideal concise reference for trainee and practicing medical oncologists, as well as those in research.
Get a quick, expert overview of the latest clinical information and guidelines for cancer checkpoint inhibitors and their implications for specific types of cancers. This practical title by Drs. Fumito Ito and Marc Ernstoff synthesizes the most up-to-date research and clinical guidance available on immune checkpoint inhibitors and presents this information in a compact, easy-to-digest resource. It’s an ideal concise reference for trainee and practicing medical oncologists, as well as those in research.
Key Features
Discusses the current understanding of how to best harness the immune system against different types of cancer at various stages.
Helps you translate current research and literature into practical information for daily practice.
Presents information logically organized by disease site.
Covers tumor immunology and biology; toxicities associated with immune checkpoint inhibitors; and future outlooks.
Consolidates today’s available information on this timely topic into one convenient resource.
Author Information
Edited by Fumito Ito, MD, PhD, Associate Professor of Oncology, Department of Surgical Oncology, Member, Center for Immunotherapy, Roswell Park Cancer Institute; Associate Professor of Surgery, Jacobs School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo, New York; Marc Ernstoff, MD, Professor and Chair, Department of Medicine, Senior Vice President for Clinical Investigation, The Katherine Anne Gioia Chair of Medicine, Roswell Park Cancer Institute and Chief, Division of Oncology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffaclo, New York
Bring it with you - The Bookshelf app allows you to access books on your laptop, tablet or mobile, so your ebooks go where ever you are - online or offline.
Take notes - Highlight, bookmark and take notes and highlights automatically stay in sync no matter where you make them.
Listen to eBooks - When you need to go screenless, the Text-to-speech tool will read your book aloud.
Powerful search - The searching capabilities allow you to search keywords through all your eBooks, the entire Bookshelf Library and well as on Wikipedia.
Ecological - Manage your environmental impact with paperless books.
How to read your VitalSource eBooks
Purchase your VitalSource eBook on the Elsevier Health site
https://www.uk.elsevierhealth.com/immune-checkpoint-inhibitors-in-cancer-9780323549486.html91562Immune Checkpoint Inhibitors in Cancerhttps://www.uk.elsevierhealth.com/media/catalog/product/9/7/9780323549486_6.jpg55.4973.99GBPInStock/Medicine and Surgery/Oncology/Books10050525503917453100005145120<p>Get a quick, expert overview of the latest clinical information and guidelines for cancer checkpoint inhibitors and their implications for specific types of cancers. This practical title by Drs. Fumito Ito and Marc Ernstoff synthesizes the most up-to-date research and clinical guidance available on immune checkpoint inhibitors and presents this information in a compact, easy-to-digest resource. It’s an ideal concise reference for trainee and practicing medical oncologists, as well as those in research.</p> <p>Get a quick, expert overview of the latest clinical information and guidelines for cancer checkpoint inhibitors and their implications for specific types of cancers. This practical title by Drs. Fumito Ito and Marc Ernstoff synthesizes the most up-to-date research and clinical guidance available on immune checkpoint inhibitors and presents this information in a compact, easy-to-digest resource. It’s an ideal concise reference for trainee and practicing medical oncologists, as well as those in research.</p>00add-to-cart97803235494862018ProfessionalEdited by Fumito Ito, MD, PhD and Marc Ernstoff, MD20191Book191w x 235h (7.50" x 9.25")Elsevier27028 Aug 2018PRINT ON DEMAND - DELIVERY CAN TAKE UP TO 10 DAYSEdited by <STRONG>Fumito Ito</STRONG>, MD, PhD, Associate Professor of Oncology, Department of Surgical Oncology, Member, Center for Immunotherapy, Roswell Park Cancer Institute; Associate Professor of Surgery, Jacobs School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo, New York; <STRONG>Marc Ernstoff</STRONG>, MD, Professor and Chair, Department of Medicine, Senior Vice President for Clinical Investigation, The Katherine Anne Gioia Chair of Medicine, Roswell Park Cancer Institute and Chief, Division of Oncology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffaclo, New YorkBooksNoNoNoNoPlease SelectPlease SelectPlease Select
